Aluminium in Over-the-Counter Drugs: Risks Outweigh Benefits?

ISSN： 0114-5916

Source： Drug Safety, Vol.26, Iss.14, 2003-01, pp. : 1011-1025

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk of Melanoma with Psoralen/Ultraviolet A Therapy for Psoriasis: Do the Known Risks Now Outweigh the Benefits?

By Lindelöf B.

Drug Safety, Vol. 20, Iss. 4, 1999-04 ,pp. : 289-297

Adis International

Access to resources Recommend Favorite

Ipilimumab: will benefits outweigh risks in the eyes of the FDA?

Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Switching of Prescription Drugs to Over-the-Counter Status: Is it a Good Thing for the Elderly?

By Francis Sally-Anne

Drugs & Aging, Vol. 22, Iss. 5, 2005-01 ,pp. : 361-370

Adis International

Access to resources Recommend Favorite

Effect of Over-the-Counter Drugs on the Unborn Child: What is Known and How Should This Influence Prescribing?

By Kacew S.

Pediatric Drugs, Vol. 1, Iss. 2, 1999-04 ,pp. : 75-80

Adis International

Access to resources Recommend Favorite

Newer Biological Agents in the Treatment of Rheumatoid Arthritis: Do the Benefits Outweigh the Risks?

By Nurmohamed Michael T.

Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. : 2035-2043

Adis International

Access to resources Recommend Favorite